Icon showing an arrow hitting the bullseye of a target

Easy deployment1

You can easily control deployment with a rotating thumbwheel that provides auditory feedback.1 The triaxial delivery system controls the stent position and keeps it in place.1

Icon with squiggly lines illustrating a stent

Consistent crush resistance1

The stent design is unique to each size to resist compression forces in different vein anatomies.1 The combination of wall thickness, strut length, and strut width is customized to each diameter to maintain consistent crush resistance.1

Icon of three sheets of paper stacked atop each other

Clinically meaningful evidence2

The inclusion of complex lesions distinguishes ABRE study 36-month results: 44% of stents in the clinical trial (88/200) crossed the inguinal ligament.2

Risks include pain, myocardial infarction, pulmonary embolism, and restenosis of stented segment.

Learn more.

Learn more about the Abre venous self-expanding stent system.

See the data.

Review the ABRE clinical study 36-month data.



Medtronic data on file. Bench testing might not be representative of clinical performance. 10558227DOC_A.


Abre stent Instructions for Use.